The PRKD1 promoter is a target of the KRas-NF-κ B pathway in pancreatic cancer

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Döppler, Heike ^a   Panayiotou, Richard ^a   Reid, Elizabeth M ^a   Maimo, Willibroad ^a   Bastea, Ligia ^a   Storz, Peter ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KRAS PROTEIN, HUMAN; PROTEIN KINASE C; PROTEIN KINASE D; PROTEIN P21;

BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PROMOTER REGION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NF-KAPPA B; PANCREATIC NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS P21(RAS); SIGNAL TRANSDUCTION;

EID: 84988807099     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep33758     Document Type: Article

References (37)

1. Almoguera, C. et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53, 549-554, doi: 0092-8674(88)90571-5 (1988)
2. Hingorani, S. R. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437-450, doi: S153561080300309X (2003).
3. Liou, G. Y. et al. Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions. Cell Rep 14, 2325-2336, doi: 10.1016/j.celrep.2016.02.029 S2211-1247(16)30132-2 (2016).
4. Ardito, C. M. et al. EGF receptor is required for KRAS-induced pancreatic tumorigenesis. Cancer Cell 22, 304-317, doi: 10.1016/j. ccr.2012.07.024 S1535-6108(12)00337-6 (2012).
5. Navas, C. et al. EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma. Cancer Cell 22, 318-330, doi: 10.1016/j.ccr.2012.08.001 S1535-6108(12)00338-8 (2012).
6. Collins, M. A. & Pasca di Magliano, M. Kras as a key oncogene and therapeutic target in pancreatic cancer. Front Physiol 4, 407, doi: 10.3389/fphys.2013.00407 (2013).
7. Pan, X. et al. Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells. Clin Cancer Res 14, 8143-8151, doi: 10.1158/1078-0432.CCR-08-1539 14/24/8143 (2008).
8. Wang, W. et al. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 5, 119-127 (1999).
9. Doppler, H., Liou, G. Y. & Storz, P. Downregulation of TRAF2 mediates NIK-induced pancreatic cancer cell proliferation and tumorigenicity. Plos One 8, e53676, doi: 10.1371/journal.pone.0053676 PONE-D-12-22714 (2013).
10. Nishina, T., Yamaguchi, N., Gohda, J., Semba, K. & Inoue, J. NIK is involved in constitutive activation of the alternative NF-kappaB pathway and proliferation of pancreatic cancer cells. Biochem Biophys Res Commun 388, 96-101, doi: 10.1016/j.bbrc.2009.07.125 S0006-291X(09)01495-8 (2009).
11. Wharry, C. E., Haines, K. M., Carroll, R. G. & May, M. J. Constitutive non-canonical NFkappaB signaling in pancreatic cancer cells. Cancer Biol Ther 8, 1567-1576, doi: 8961 (2009).
12. Ling, J. et al. KrasG12D-induced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell 21, 105-120, doi: 10.1016/j.ccr.2011.12.006 S1535-6108(11)00475-2 (2012).
13. Maniati, E. et al. Crosstalk between the canonical NF-kappaB and Notch signaling pathways inhibits Ppargamma expression and promotes pancreatic cancer progression in mice. J Clin Invest 121, 4685-4699, doi: 10.1172/JCI45797 45797 (2011).
14. Zhang, W. et al. Emodin sensitizes the gemcitabine-resistant cell line Bxpc-3/Gem to gemcitabine via downregulation of NF-kappaB and its regulated targets. Int J Oncol 42, 1189-1196, doi: 10.3892/ijo.2013.1839 (2013).
15. Cao, L. P., Song, J. L., Yi, X. P. & Li, Y. X. Double inhibition of NF-kappaB and XIAP via RNAi enhances the sensitivity of pancreatic cancer cells to gemcitabine. Oncol Rep 29, 1659-1665, doi: 10.3892/or.2013.2246 (2013).
16. Daniluk, J. et al. An NF-kappaB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice. J Clin Invest 122, 1519-1528, doi: 10.1172/JCI59743 59743 (2012).
17. Chen, L. A. et al. PKD3 is the predominant protein kinase D isoform in mouse exocrine pancreas and promotes hormone-induced amylase secretion. J Biol Chem 284, 2459-2471, doi: M801697200 10.1074/jbc.M801697200 (2009).
18. Liou, G. Y. et al. Protein kinase D1 drives pancreatic acinar cell reprogramming and progression to intraepithelial neoplasia. Nat Commun 6, 6200, doi: 10.1038/ncomms7200 ncomms7200 (2015).
19. Ferdaoussi, M. et al. G protein-coupled receptor (GPR)40-dependent potentiation of insulin secretion in mouse islets is mediated by protein kinase D1. Diabetologia 55, 2682-2692, doi: 10.1007/s00125-012-2650-x (2012).
20. Trauzold, A. et al. PKCmu prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells. Oncogene 22, 8939-8947, doi: 10.1038/sj.onc.1207001 1207001 (2003).
21. Guha, S., Tanasanvimon, S., Sinnett-Smith, J. & Rozengurt, E. Role of protein kinase D signaling in pancreatic cancer. Biochem Pharmacol 80, 1946-1954, doi: 10.1016/j.bcp.2010.07.002 S0006-2952(10)00488-0 (2010).
22. Harikumar, K. B. et al. A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo. Mol Cancer Ther 9, 1136-1146, doi: 10.1158/1535-7163.MCT-09-1145 1535-7163.MCT-09-1145 (2010).
23. Kisfalvi, K., Guha, S. & Rozengurt, E. Neurotensin and EGF induce synergistic stimulation of DNA synthesis by increasing the duration of ERK signaling in ductal pancreatic cancer cells. J Cell Physiol 202, 880-890, doi: 10.1002/jcp.20187 (2005).
24. Shabelnik, M. Y. et al. Differential expression of PKD1 and PKD2 in gastric cancer and analysis of PKD1 and PKD2 function in the model system. Exp Oncol 33, 206-211, doi: 2253 (2011).
25. Yuan, J. et al. Protein kinase d regulates cell death pathways in experimental pancreatitis. Front Physiol 3, 60, doi: 10.3389/ fphys.2012.00060 (2012).
26. Yuan, J. et al. Protein kinase D1 mediates NF-kappaB activation induced by cholecystokinin and cholinergic signaling in pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol 295, G1190-G1201, doi: 10.1152/ajpgi.90452.2008 90452.2008 (2008).
27. Yuan, J. & Rozengurt, E. PKD, PKD2, and p38 MAPK mediate Hsp27 serine-82 phosphorylation induced by neurotensin in pancreatic cancer PANC-1 cells. J Cell Biochem 103, 648-662, doi: 10.1002/jcb.21439 (2008).
28. Bang, D., Wilson, W., Ryan, M., Yeh, J. J. & Baldwin, A. S. GSK-3alpha promotes oncogenic KRAS function in pancreatic cancer via TAK1-TAB stabilization and regulation of noncanonical NF-kappaB. Cancer Discov 3, 690-703, doi: 10.1158/2159-8290.CD-12-0541 2159-8290.CD-12-0541 (2013).
29. Borges, S. et al. Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis. Breast Cancer Res 15, R66, doi: 10.1186/bcr3460 bcr3460 (2013).
30. Natoli, G., Saccani, S., Bosisio, D. & Marazzi, I. Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nat Immunol 6, 439-445, doi: ni1196 10.1038/ni1196 (2005).
31. Chen, F. E. & Ghosh, G. Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views. Oncogene 18, 6845-6852, doi: 10.1038/sj.onc.1203224 (1999).
32. Kim, M. et al. Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion. Carcinogenesis 29, 629-637, doi: 10.1093/carcin/bgm291 bgm291 (2008).
33. Prabhu, L., Mundade, R., Korc, M., Loehrer, P. J. & Lu, T. Critical role of NF-kappaB in pancreatic cancer. Oncotarget 5, 10969-10975, doi: 2624 10.18632/oncotarget.2624 (2014).
34. Storz, P. & Toker, A. Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway. EMBO J 22, 109-120, doi: 10.1093/emboj/cdg009 (2003).
35. Eiseler, T., Doppler, H., Yan, I. K., Goodison, S. & Storz, P. Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion. Breast Cancer Res 11, R13, doi: 10.1186/bcr2232 bcr2232 (2009).
36. Anrather, J., Csizmadia, V., Soares, M. P. & Winkler, H. Regulation of NF-kappaB RelA phosphorylation and transcriptional activity by p21(ras) and protein kinase Czeta in primary endothelial cells. J Biol Chem 274, 13594-13603 (1999).
37. Olive, K. P. et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324, 1457-1461, doi: 10.1126/science.1171362 1171362 (2009).